CHK, VRX, ATK, RMD, CNL, GET Expected To Be Higher Leading Up To Next Earnings Releases
July 30, 2009 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed before their last 12 quarterly, 6 quarterly and July/August earnings reports. Chesapeake Energy (NYSE: CHK), Valeant Pharmaceuticals (NYSE: VRX), Alliant Techsystems (NYSE: ATK), ResMed (NYSE: RMD), Cleco (NYSE: CNL) and Gaylord Entertainment (NYSE: GET) are all expected to be higher leading up to their next earnings release. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act before its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go higher leading up to their next earnings release:
Symbol Company # of Reports Quarter Release Date
CHK Chesapeake Energy Corp. August earnings Q2 8/3/2009
VRX Valeant Pharmaceuticals August earnings Q2 8/4/2009
ATK Alliant Techsystems Inc 12 quarters Q1 8/6/2009
RMD ResMed Inc. August earnings Q4 8/6/2009
CNL Cleco Corp August earnings Q2 8/5/2009
GET Gaylord Entertainment August earnings Q2 8/4/2009
Earnings, or profits, drive stock prices. The market values a company based on its current and anticipated future ability to make money. The market takes the earnings pulse of a company four times per year when quarterly reports are issued. When this information is released it can often be a trend-changing or a trend confirming event because the information is so vital to the market's perception of the vitality of that company.
This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.
Chesapeake Energy Corporation (NYSE: CHK), an oil and natural gas exploration and production company, engages in the acquisition, exploration, and development of properties for the production of crude oil and natural gas from underground reservoirs. It also provides marketing and midstream services for natural gas and oil for other working interest owners in properties it operate. The companya�s properties are located in Oklahoma, Texas, Alabama, Arkansas, Louisiana, Kansas, Montana, Colorado, North Dakota, Nebraska, New Mexico, West Virginia, Kentucky, Ohio, New York, Maryland, Michigan, Mississippi, Pennsylvania, Tennessee, Utah, Virginia, and Wyoming. As of December 31, 2008, it owned interests in approximately 41,200 producing natural gas and oil wells; and had 12.051 trillion cubic feet equivalent of proved reserves. The company was founded in 1989 and is based in Oklahoma City, Oklahoma.
Valeant Pharmaceuticals International (NYSE: VRX), a specialty pharmaceutical company, engages in the development, manufacture, and marketing of a range of pharmaceutical products. It primarily offers specialty pharmaceutical and over-the-counter (OTC) products in the areas of dermatology and neurology therapeutic classes. The companya�s products include Efudex/Efudix for the treatment of multiple actinic or solar keratoses and superficial basal cell carcinoma; Diastat/Diastat AcuDial, which are gel formulations of diazepam; Cesamet, a synthetic cannabinoid used for the management of severe nausea and vomiting; Bedoyecta, a brand of vitamin B complex; Bisocard to treat hypertension and angina pectoris; and Kinerase, a range of OTC and prescription cosmetic products. It also offers Mestinon, an orally active cholinesterase inhibitor used in the treatment of myasthenia gravis; M.V.I., a hospital dietary supplement used in treating trauma and burns; Migranal, a nasal spray formulation for the treatment of acute migraine headaches; Nyal to treat cough, cold, flu, sinus, and hayfever symptoms; and Virazole for the treatment of hospitalized infants and young children with lower respiratory tract infections. As of December 31, 2008, its product portfolio comprised approximately 389 products, with approximately 982 stock keeping units. The company markets its pharmaceutical products to physicians, hospitals, pharmacies, and wholesalers through its sales force, as well as through wholesalers in the United States, Mexico, Poland, and Canada. It has a collaboration agreement with Glaxo Group Limited to develop and commercialize retigabine, a neuronal potassium channel opener for the treatment of adult epilepsy patients with refractory partial onset seizures. Valeant Pharmaceuticals was founded in 1960 and is headquartered in Aliso Viejo, California.
Alliant Techsystems Inc. (NYSE: ATK) supplies aerospace and defense products to the U.S. government agencies, and its prime contractors and subcontractors. The company also supplies ammunition and related accessories to law enforcement agencies and commercial customers. Its ATK Armament Systems segment offers military ammunition and gun systems, such as small-caliber training and tactical ammunition rounds; medium-caliber ammunition, including fighting and light armored vehicles, helicopters, A-10 close-combat support aircraft, and AC-130 gunship aircraft; and chain guns. This segment also provides ammunition, gun care products, targets and traps, rifle scopes and mounts, and binoculars to law enforcement agencies and sport shooting enthusiasts; solid extruded propellant for medium caliber and tank ammunition, artillery charge systems, and air and ground launched rockets; and commercial gun powder for sporting ammunition manufacturers, hunters, and sport shooters. The companya�s ATK Mission Systems segment offers missile systems, precision-guided munitions, force protection systems, soldier weapon systems, barrier systems, large-caliber ammunition, tactical and hypersonic propulsion systems, warheads, fuzes, missile defense divert and control systems, electronic warfare and aircraft integration products, structural and engine components, radomes, and apertures. Alliant Techsystemsa� ATK Space Systems segment manufactures human and cargo launch vehicles, conventional and strategic missiles, missile defense interceptors, and decoy and illuminating flares. This segment also offers solar arrays and solar panel substrates; radio frequency antenna reflectors and antennas; composite bus structures, towers, and subsystems; thermal systems; titanium propellant tanks; and insertion motors, as well as technical services. It operates in the United States, Puerto Rico, and internationally. The company was founded in 1990 and is headquartered in Minneapolis, Minnesota.
ResMed, Inc. (NYSE: RMD), through its subsidiaries, engages in the design, manufacture, and marketing of equipment for the diagnosis and treatment of sleep-disordered breathing and other respiratory disorders. Its portfolio of products for the treatment of obstructive sleep apnea and other forms of sleep-disordered breathing include airflow generators, diagnostic products, mask systems, headgear, and other accessories, such as cold passover humidifiers, carry bags, and breathing circuits. The company also offers data communications and control products, such as the ResLink, ResControl, ResControl II, TxControl, ResScan, and ResTraxx modules that facilitate the transfer of data and other information to and from the flow generators. ResMed, Inc. sells its products worldwide through a network of distributors, independent manufacturersa� representatives, and direct sales force. The company was founded in 1989 and is based in Poway, California.
Cleco Corporation (NYSE: CNL), through its subsidiaries, engages in the generation, transmission, distribution, and sale of electricity in Louisiana. As of December 31, 2008, it had ownership interest in 3 steam electric generating stations and 1 gas turbine with a net electric generating capacity of 1,318 megawatts. The company served approximately 276,000 customers in 107 communities in central and southeastern Louisiana. Cleco Corporation was founded in 1934 and is based in Pineville, Louisiana.
Gaylord Entertainment Company (NYSE: GET), through its subsidiaries, operates as a diversified hospitality and entertainment company in the United States. The company focuses on the large group meetings and conventions sector of the lodging market. It owns and operates the Gaylord Hotels branded hotels, which include the Gaylord Opryland Resort and Convention Center in Nashville, Tennessee; the Gaylord Palms Resort and Convention Center in Kissimmee, Florida; the Gaylord Texan Resort and Convention Center in Grapevine, Texas; and the Gaylord National Resort & Convention Center located on the Potomac River in Prince Georgea�s County, Maryland. Gaylord Entertainment Company also owns and operates the Radisson Hotel at Opryland in Nashville, Tennessee. In addition, the company operates the Nashville-based tourist attractions, which comprise the Grand Ole Opry, a live country music variety show; the General Jackson Showboat, a 300-foot, four-deck paddle wheel showboat, on the Cumberland river; the Wildhorse Saloon, a country music performance venue; the Ryman Auditorium, a venue for concerts and musical productions; and the Gaylord Springs Golf Links, a golf course located near the Opryland complex. Further, it engages in the production of creative events in the corporate entertainment marketplace, as well as the ownership and operation of the WSM-AM radio station. The company was founded in 1955 and is headquartered in Nashville, Tennessee.
SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com
One example from the SqueezeTrigger database is approximately 2.5 billion short sale transactions going back to January 1, 2005, and SqueezeTrigger calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data. Total Short Interest is the number of shares shorted but not yet covered, and is different from total short volume. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com
Go to www.SqueezeTrigger.com to find out the exact price that the entire Total Short Interest will start covering!
About SQUEEZETRIGGER.COM
WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.
SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha�s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.
All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.
Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.
By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.
Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.
Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.
Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641